Equillium Inc expected to post a loss of 33 cents a share - Earnings Preview
02/05/2025 13:06
Equillium Inc EQ.OQ EQ.O is expected to show a fall in quarterly revenue when it reports results on May 5 (estimated) for the period ending March 31 2025 LSEG's mean analyst estimate for Equillium Inc is for a loss of 33 cents per share. The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The mean earnings estimate of analysts had fallen by about 14.8% in the last three months. Wall Street's median 12-month price target for Equillium Inc is $1.00, above its last closing price of $0.41. This summary was machine generated May 2 at 12:06 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Equillium
See all newsBrief: Equillium Receives Australian Regulatory Clearance To Initiate First-In-Human Clinical Trial Of Eq504
Equillium Inc reports results for the quarter ended June 30 - Earnings Summary
Equillium Q2 post narrower net loss than expected; starts R&D initiatives
Equillium Inc expected to post a loss of 5 cents a share - Earnings Preview
Equillium Q1 net loss, profit miss analyst expectations